Abstract
Diabetic nephropathy is a major cause of morbidity and mortality in diabetic patients. To prevent the development of this disease and to improve advanced kidney injury, effective therapies directed toward the key molecular target are required. In this paper, the efficacy of fenugreek to restore the kidney function of diabetic rats via its antioxidant and anti-inflammatory activities has been studied. Novel data showing the efficacy of fenugreek to attenuate progression of diabetic nephropathy and production of interleukin-6 (IL-6) in rats compared with a diabetic untreated group were obtained. Rats were classified into five groups; control, diabetic untreated, and three diabetic groups treated with fenugreek, rosiglitazone, and metformin. Treatment with fenugreek has been continued for 12 weeks. Fenugreek was found to significantly reduce the high levels of glucose, urea, creatinine, sodium, potassium, and IL-6 in serum compared with the diabetic untreated group. In addition, levels of malondialdehyde and IL-6 in the kidney homogenate were significantly reduced as a result of the fenugreek treatment compared with the diabetic untreated group. Moreover, concentration of GSH and the activity of both superoxide dismutase and catalase were considerably increased in the diabetic treated groups compared with the diabetic untreated group. Furthermore, glomerular mesangial expansion was reduced in the treated animal groups. These findings suggest a therapeutic potential of fenugreek against diabetic nephropathy, explain its antioxidative/anti-inflammatory properties and provide a direction for future research.
Similar content being viewed by others
References
Abdel-Bary JA, Abdel Hassan IA, Al-Hakiem MHH (1997) Hypoglycemic and antihyperglycemic effect of Trigonella foenum graecum leaf in normal and alloxan induced diabetic rats. J Ethnopharmacol 58:149–155
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126
Al-Shamanty J, Shahba M, Al Khazraji Twaij HAA (1994) Hypoglycemic effect of Artemisia herb alba II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol 43:167–171
Ankrah NA (1995) Alterations of glucose tolerance in mice fed low levels of aflatoxins and with depressed glyoxalase I activity. Vet Hum Toxicol 37:59–61
Ashokkumar N, Pari L (2005) Effect of N-benzoyl-d-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta 351:105–113
Brouwers O, Niessen PM, Haenen G, Miyata T, Brownlee M, Stehouwer CD, De Mey JG, Schalkwijk CG (2010) Hyperglycemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 53:989–1000
Choudhary D, Chandra D, Choudhary S, Kale RK (2001) Modulation of glyoxalase, glutathione S-transferase and antioxidant enzymes in the liver, spleen and erythrocytes of mice by dietary administration of fenugreek seeds. Food Chem Toxicol 39:989–997
Ethan-Basch CU, Kuo G, Szapary P, Smith M (2003) Therapeutic applications of fenugreek. Altern Med Rev 8:20–27
Fukuzawa Y, Watanabe Y, Inaguma D, Hotta N (1996) Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state. J Lab Clin Med 128:568–578
Hamden K, Masmoudi H, Carreau S, Elfeki A (2010) Immunomodulatory, β-cell, and neuroprotective actions of fenugreek oil from alloxan-induced diabetes. Immunopharmacol Immunotoxicol Immunopharmacol Immunotoxicol 32:437–445
Hannan JMA, Ali L, Rokeya B, Khaleque J, Akhter M, Flatt PR, Abdel-Wahab YA (2007) Soluble dietary fiber fraction of Trigonella foenum graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr 97:514–521
Haque N, Salma U, Nurunnabi TR, Uddin MJ, Jahangir MF, Islam SM, Kamruzzaman M (2011) Management of type 2 diabetes mellitus by lifestyle, diet and medicinal plants. Pak J Biol Sci 14:13–24
Kanter M (2009) Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy. J Mol Hist 40:107–115
Mao Z, Ye S, Zhai Z, Chen Y, Li X, Yang G, Fan A, Wang Y (2009) Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal monocyte chemoattractant protein-1 expression. J Diabetes Complications 23:124–129
Morcos SR, Elhawary Z, Gabrial GN (1981) Protein rich food mixtures for feeding the young in Egypt. 1. Formulation. Z Ernährungswiss 20:275–282
Morcos M, Sayed AAR, Bierhaus A, Yard B, Waldherr R, Merz W, Kloeting I, Schleicher E, Mentz S, el Baki RFAbd, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi KA, Schmidt A-M, Stern D, Ziegler R, Haering HU, Andrassy M, van der Woude F, Nawroth PP (2002) Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 51:3532–3544
Morcos M, Schlotterer A, Sayed AAR, Kukudov G, Oikomonou D, Ibrahim Y, Pfisterer F, Schneider J, Bozorgmehr F, Rudofsky G Jr, Schwenger V, Kientsch-Engels R, Hamann A, Zeier M, Dugi K, Yard B, Humpert PM, van der Woude F, Nawroth PP, Bierhaus A (2008) Rosiglitazone reduces angiotensin ii and advanced glycation end product-dependent sustained nuclear factor-κB activation in cultured human proximal tubular epithelial cells. Horm Metab Res 40:752–759
Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 67:582–589
Nishikimi M, Roa NA, Yogi K (1972) The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 46:849–854
Okhawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissue by thiobarbituric acid. Anal Biochem 95:355–358
Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ (2001) Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 244:45–51
Sauerheber RD, Kuhn CE, Hyslop PA (1984) Membrane structural/functional properties of adipocytes from normal and streptozotocin-diabetic rats. Diabetes 33:258–265
Sayed AA (2008) Thymoquinone protects tubular epithelial cells against tubular injury. Cell Biochem Funct 26:374–380
Sayed AA (2011) Ferulsinaic acid attenuation of AGEs extends life span of Caenorhabditis elegans. J Pharm Pharmacol 63:423–428
Sayed AA (2012) Thymoquinone and proanthocyanidin attenuation of diabetic nephropathy in rats. Eur Rev Med Pharmacol Sci (in press)
Sayed AA, El-Shaieb K, Mourad A (2012) Life span extension of Caenorhabditis elegans by Novel pyrido perimidine drevative. Arch Pharmacal Res (in press)
Xue W, Lei J, Li X, Zhang R (2011) Trigonella foenum graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity. Nutr Res 31:555–562
Xue W, Li X, Zhang J, Liu Y, Wang Z, Zhang R (2007) Effect of Trigonella foenum graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 16:422–426
Acknowledgements
The authors acknowledge the scientific guidance and continuous advice of Dr. Michael Morcos, Faculty of Medicine, Heidelberg University, Heidelberg, Germany. Deep thanks are for Dr. Wafaee Gomaa, Pathology Department, Faculty of Medicine, Minia University, El-Minia, Egypt, who did the histopathological examination of the kidneys.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sayed, A.A.R., Khalifa, M. & Abd el-Latif, F.F. Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats. J Physiol Biochem 68, 263–269 (2012). https://doi.org/10.1007/s13105-011-0139-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-011-0139-6